Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Climate engineering would alter the oceans, reshaping marine life – our new study examines each method’s risks14.01.2026 - 2Hundreds show fascist salute at rally in Rome in annual ritual07.01.2026
- 33 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 202505.12.2025
- 4Displaced Palestinian families suffer as heavy rains flood Gaza tent camps14.11.2025
- 5She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'06.11.2025
- Four countries to boycott Eurovision 2026 over Israel’s inclusion
- People with depression can treat themselves at home with new device
- Is 'Veronica Mars' about to be your new binge-watch? It's now streaming on Netflix.
- Holiday destinations for Creature Sweethearts
- Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
- 4 Must-Visit bar-b-que Eateries This Year
- The most effective method to Alter Your Savvy Bed for A definitive Rest Insight
- A definitive Burger Confrontation: Which One Rules?
- Want to make America healthy again? Stop fueling climate change
